Research highlights the potential diagnostic value of the newly described “Y-sign” in patients with optic nerve hypoplasia
Jonathon Tong, MD, resident, and colleagues from the WashU Medicine John F. Hardesty, MD, Department of Ophthalmology & Visual Sciences recently published a study titled, “Characterization of a Novel MRI Sign of the Optic Chiasm in Patients With Optic Nerve Hypoplasia,” describing a newly identified imaging finding that may aid in the diagnosis of optic nerve hypoplasia (ONH).
Optic nerve hypoplasia is a congenital condition characterized by underdevelopment of the optic nerves, which transmit visual information from the eyes to the brain. The disorder is one of the most common causes of childhood visual impairment and can be associated with a wide range of visual and neurological outcomes.
In the study, researchers investigated a previously undescribed magnetic resonance imaging (MRI) finding involving the optic chiasm, which they termed the “Y-sign.” The team evaluated the presence of this imaging feature in patients diagnosed with ONH and assessed its potential utility as a diagnostic marker.
The investigators found that the Y-sign demonstrated high specificity and mild sensitivity for optic nerve hypoplasia, suggesting that when present, the finding may serve as a reliable indicator of the condition. The study also identified patient groups in which the Y-sign was more commonly observed, including children younger than one year of age and patients with bilateral optic nerve hypoplasia.
These findings provide clinicians and radiologists with a novel imaging feature that may support the identification of ONH, particularly in complex or uncertain cases. Earlier recognition of optic nerve hypoplasia can help guide appropriate ophthalmic, neurological, and developmental evaluations for affected children.
In addition to its diagnostic potential, the authors note that further investigation of the Y-sign may provide new insights into the anatomical changes associated with optic nerve hypoplasia and their relationship to long-term clinical outcomes.
This work reflects the department’s commitment to advancing pediatric ophthalmology and neuro-ophthalmology research through innovative approaches that improve the diagnosis and management of vision-threatening conditions in children.